Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enzon begins patient treatment in phase I trial of PEG-paclitaxel

May 9, 2001

MGI's lead acylfulvene advances to phase II for refractory sarcoma

May 9, 2001

Preclinical profile of Bay-59-8862, a new taxane, reviewed in Drugs of the Future

May 8, 2001

MAbs prepared at Genentech act as HGF receptor antagonists

May 8, 2001

Cell Pathways and BMS to initiate drug combination study for first-line NSCLC

May 8, 2001

Preclinical antiproliferative activity of A-105972 characterized

May 8, 2001

Phase II trial of irofulven for treatment of glioma commences

May 8, 2001

Pharmacyclics reacquires worldwide rights to Lutrin

May 8, 2001

New kinase inhibitors under study at Pfizer

May 7, 2001

Research at BASF leads to identification of inhibitors of angiogenic kinases

May 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...